↓ Skip to main content

Potential of epigenetic therapies in non-cancerous conditions

Overview of attention for article published in Frontiers in Genetics, December 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
6 X users
facebook
2 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Potential of epigenetic therapies in non-cancerous conditions
Published in
Frontiers in Genetics, December 2014
DOI 10.3389/fgene.2014.00438
Pubmed ID
Authors

Theresa Mau, Raymond Yung

Abstract

There has been an explosion of knowledge in the epigenetics field in the past 20 years. The first epigenetic therapies have arrived in the clinic for cancer treatments. In contrast, much of the promise of epigenetic therapies for non-cancerous conditions remains in the laboratories. The current review will focus on the recent progress that has been made in understanding the pathogenic role of epigenetics in immune and inflammatory conditions, and how the knowledge may provide much needed new therapeutic targets for many autoimmune diseases. Dietary factors are increasingly recognized as potential modifiers of epigenetic marks that can influence health and diseases across generations. The current epigenomics revolution will almost certainly complement the explosion of personal genetics medicine to help guide treatment decisions and disease risk stratification.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 4%
Unknown 53 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 20%
Student > Ph. D. Student 10 18%
Researcher 8 15%
Student > Bachelor 6 11%
Student > Postgraduate 4 7%
Other 11 20%
Unknown 5 9%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 24%
Medicine and Dentistry 13 24%
Agricultural and Biological Sciences 10 18%
Chemistry 3 5%
Immunology and Microbiology 2 4%
Other 7 13%
Unknown 7 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2015.
All research outputs
#6,309,279
of 23,306,612 outputs
Outputs from Frontiers in Genetics
#1,859
of 12,325 outputs
Outputs of similar age
#84,174
of 355,904 outputs
Outputs of similar age from Frontiers in Genetics
#28
of 111 outputs
Altmetric has tracked 23,306,612 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 12,325 research outputs from this source. They receive a mean Attention Score of 3.7. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,904 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 111 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.